Search General Info
Search Education
Search Partnering Companies
photo
Speaker

Stephen Bloch, MD

CHIEF EXECUTIVE OFFICER, EVOLVEIMMUNE THERAPEUTICS, INC.
Westport, Connecticut, United States
Steve Bloch is the co-founder and CEO of EvolveImmune. Before co-founding EvolveImmune, Steve helped start and finance leading healthcare companies as a general partner at Canaan Partners. Steve currently serves on the boards of companies in biopharma (Liquidia (LQDA – NASDAQ, board chairman), digital health (Truveris, Ambra Health, Corvium and Genome Medical), and medical devices (Onkos Surgical). Past board roles include Amicus Therapeutics (FOLD-NASDAQ), Marinus Pharmaceuticals (MRNS-NASDAQ) and Advanced BioHealing (M&A with Shire).
Steve obtained his AB from Dartmouth College, a MA in the history of science from Harvard, and his medical degree from the University of Rochester. Steve completed his residency at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine).
Speaking In
[On Demand]
EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in the Yale/New…